KM

Kasarla Mahender

Active Director Director DIN 11066020
DIN 11066020 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kasarla Mahender

Data last updated:

Kasarla Mahender is a Director at Sparkem Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11066020
Primary Designation Director
Industry Pharma
First Appointment 20 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Apr 20252025Active

Board colleagues of Kasarla Mahender

NameDINCompanyDesignation
Raju Jannu11066021Sparkem Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sparkem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kasarla Mahender

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kasarla Mahender

Kasarla Mahender currently holds 1 directorship: Sparkem Pharmaceuticals Private Limited (Director, since 20 Apr 2025).

Kasarla Mahender was first appointed on 20 Apr 2025 as Director at Sparkem Pharmaceuticals Private Limited.

The current boards of Kasarla Mahender's companies include Raju Jannu (Sparkem Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available